These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23826353)

  • 61. Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
    De Cock E; Krueger WA; Sorensen S; Baker T; Hardewig J; Duttagupta S; Müller E; Piecyk A; Reisinger E; Resch A
    Infection; 2009 Apr; 37(2):123-32. PubMed ID: 19277465
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
    Mendes RE; Deshpande LM; Smyth DS; Shopsin B; Farrell DJ; Jones RN
    J Clin Microbiol; 2012 Nov; 50(11):3694-702. PubMed ID: 22972817
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
    Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
    Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    Kidd JM; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2019 Apr; 74(4):970-977. PubMed ID: 30561650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
    Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.
    Miyazaki T; Yanagihara K; Kakeya H; Izumikawa K; Mukae H; Shindo Y; Yamamoto Y; Tateda K; Tomono K; Ishida T; Hasegawa Y; Niki Y; Watanabe A; Soma K; Kohno S
    J Infect Chemother; 2020 Feb; 26(2):242-251. PubMed ID: 31575499
    [TBL] [Abstract][Full Text] [Related]  

  • 67.
    Barman TK; Kumar M; Mathur T; Namba E; Singh D; Chaira T; Kurosaka Y; Yamada M; Upadhyay DJ; Masuda N
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610202
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterisation of clinical meticillin-resistant Staphylococcus epidermidis demonstrating high levels of linezolid resistance (>256 μg/ml) resulting from transmissible and mutational mechanisms.
    Gabriel EM; Fitzgibbon S; Clair J; Coffey A; O'Mahony JM
    J Infect Chemother; 2015 Jul; 21(7):547-9. PubMed ID: 25913534
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
    Walkey AJ; O'Donnell MR; Wiener RS
    Chest; 2011 May; 139(5):1148-1155. PubMed ID: 20864609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New therapy options for MRSA with respiratory infection/pneumonia.
    Ramirez P; Fernández-Barat L; Torres A
    Curr Opin Infect Dis; 2012 Apr; 25(2):159-65. PubMed ID: 22248980
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.
    Tong MC; Wisniewski CS; Wolf B; Bosso JA
    Pharmacotherapy; 2016 Jul; 36(7):731-9. PubMed ID: 27208687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
    Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
    Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia.
    Chen C; Fan H; Huang Y; Peng F; Fan H; Yuan S; Tong Y
    Biomed Res Int; 2014; 2014():602185. PubMed ID: 25136599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
    Peyrani P; Ramirez J
    Curr Opin Infect Dis; 2015 Apr; 28(2):164-70. PubMed ID: 25692268
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms.
    Guo P; Buttaro BA; Xue HY; Tran NT; Wong HL
    Eur J Pharm Biopharm; 2020 Jun; 151():189-198. PubMed ID: 32335285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Community-acquired meticillin-resistant Staphylococcus aureus strain USA300 resists staphylococcal protein A modulation by antibiotics and antimicrobial peptides.
    Cardot Martin E; Michel A; Raynal B; Badiou C; Laurent F; Vandenesch F; Etienne J; Lina G; Dumitrescu O
    Int J Antimicrob Agents; 2015 Jan; 45(1):19-24. PubMed ID: 25450803
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nosocomial MRSA pneumonia: data from recent clinical trials.
    Karvouniaris M; Makris D; Karabekos D; Zakynthinos E
    Rev Recent Clin Trials; 2011 Sep; 6(3):235-40. PubMed ID: 21682676
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Severe ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus and other pathogens: report of a case successfully managed by serial surveillance cultures of endotracheal aspirates.
    Sakai C; Soda H
    J Infect Chemother; 2011 Jun; 17(3):424-8. PubMed ID: 20862506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-MRSA drug use and antibiotic susceptibilities of MRSA at a university hospital in Japan from 2007 to 2011.
    Shigemura K; Osawa K; Mukai A; Yoshida H; Fujisawa M; Arakawa S
    J Antibiot (Tokyo); 2013 May; 66(5):273-6. PubMed ID: 23531989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4.
    Chen YG; Zhang Y; Deng LQ; Chen H; Zhang YJ; Zhou NJ; Yuan K; Yu LZ; Xiong ZH; Gui XM; Yu YR; Wu XM; Min WP
    PLoS One; 2016; 11(3):e0149233. PubMed ID: 26974438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.